|
|
Afro-C interim results June 2025
Continuing operations
These are the maiden interim results following the change in year end from June to December, therefore are incomparable. Revenue from contracts with customers was R4.2 billion, whilst the net insurance result of R10.5 million was recorded. Profit for the period attributable to owners of the parent came in at R101.0 million. Furthermore, headline earnings per share from total operations was 11.68 cents per share.
Dividend
No dividend has been declared for the period.
Investor presentation
Management will host a virtual investor presentation tomorrow, Wednesday, 03 September 2025 at 10:00 SAST. The webcast will be accessible at http://www.acinterim2025.co.za
Company outlook
The focus for the remainder of 2025 will be to deliver on our strategic priorities in pursuit of our 2030 ambition and set our business on an exciting new growth trajectory. We will be focused on a more cohesive and integrated operating model that leverages the unique strengths of our diversified businesses.
As we move forward:
Clinical innovation will become a key differentiator for our business. Critically, our track record to unlock significant value on Clinical Managed Care will remain a key asset and a success factor will be to transform traditional care delivery programmes to focus on value-based care.
We will unlock our core strengths in service delivery, allowing us to proactively respond to our customer needs, deliver exceptional experiences for our clients and members, and running an efficient business that is digitally enabled.
We will continue to focus on key partnerships with our schemes, intermediaries and service providers to grow our networks and deliver a compelling proposition that is data and digitally enabled.
We will work tirelessly to build trust and demonstrate our commitment to making a positive impact on the lives of those we serve, and most importantly, ensure the well-being of our people to remain motivated and engaged.
AfroCentric enters the second half of 2025 with a clear focus on delivering against our strategic priorities and advancing our Vision 2030 ambition. While we maintain a leading market position, we remain vigilant to both internal and external factors that could influence our trajectory.
Externally, regulatory developments including ongoing NHI discussions and the recent Council of Medical Schemes (CMS) Low-Cost Benefit Options (LCBOs) report recommending the phasing out of Primary Health Insurance continue to shape the healthcare landscape and require agile strategic responses.
Internally, we are navigating a complex operating environment that includes performance pressures in certain clusters, evolving client needs, and the natural dynamics of client contract renewals. Despite these challenges the Groups core business remains sound and competitive.
Our diversified healthcare assets, strong partnerships, and prudent capital management position us well to respond to market shifts and unlock new opportunities.
We are committed to developing a cohesive value proposition that leverages our strengths in a more integrated and scalable way, ensuring we continue to deliver sustainable value to shareholders.
|
|
Click here for original article
|
| |
| |
| Click here for full news archive for this company |
|
| Closing price data source: JSE Ltd. All other statistics calculated by ProfileData. |
| |
|
|
